Travis Mickle
Presidente presso KemPharm Denmark A/S
Patrimonio netto: 261 418 $ in data 31/05/2024
Profilo
Travis C.
Mickle was the founder of Zevra Therapeutics, Inc. founded in 2006, where he held the title of President & Director in 2023.
Currently, he is the Chairman at KemPharm Denmark A.
In the past, he worked as the Director-Drug Discovery & Chemical Development at New River Pharmaceuticals, Inc. from 2003 to 2005.
Dr. Mickle received his undergraduate degree from Simpson College in 1995 and his doctorate degree from the University of Iowa in 2000.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC.
0.13% | 22/03/2024 | 56 219 ( 0.13% ) | 261 418 $ | 31/05/2024 |
Posizioni attive di Travis Mickle
| Società | Posizione | Inizio |
|---|---|---|
KemPharm Denmark A/S
 KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Presidente | 13/05/2022 |
Precedenti posizioni note di Travis Mickle
| Società | Posizione | Fine |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Amministratore Delegato | 25/04/2023 |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01/10/2005 |
Formazione di Travis Mickle
| Simpson College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
KemPharm Denmark A/S
KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Commercial Services |
- Borsa valori
- Insiders
- Travis Mickle
